Whitton A C, Bloom H J
Department of Radiotherapy, Royal Marsden Hospital, Sutton, Surrey, England.
Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):783-6. doi: 10.1016/0360-3016(90)90397-3.
Eighty-eight adult patients with histologically verified cerebral low grade gliomas (grades 1 and 2) treated with post-operative radiotherapy at the Royal Marsden Hospital between 1960 and 1985 were reviewed. Survival of oligodendroglioma patients was greater than those with astrocytoma (64% vs 36% at 5 years) but the difference was less marked in the long term (35% vs 26% at 10 years). Previous studies have identified prognostic factors important in these tumors: age, extent of surgery, grade, performance status, and duration of symptoms. In this study of low grade astrocytomas and oligodendrogliomas, age (highly significant in the former and significant in the latter), extent of surgery (oligodendrogliomas), and performance status have been demonstrated as factors influencing outcome. The precise role of radiotherapy including the optimal radiation dose and timing of treatment remains unclear. The information, given by a retrospective analysis such as this, helps in the design of prospective, randomized studies looking at radiation dose and time of surgical and radiotherapeutic interventions, always with careful assessment needed of quality of life and treatment morbidity.
对1960年至1985年间在皇家马斯登医院接受术后放疗的88例经组织学证实的成人脑低级别胶质瘤(1级和2级)患者进行了回顾性研究。少突胶质细胞瘤患者的生存率高于星形细胞瘤患者(5年时分别为64%和36%),但长期来看差异不那么明显(10年时分别为35%和26%)。以往的研究已经确定了这些肿瘤中重要的预后因素:年龄、手术范围、分级、功能状态和症状持续时间。在这项关于低级别星形细胞瘤和少突胶质细胞瘤的研究中,年龄(在前者中高度显著,在后者中显著)、手术范围(少突胶质细胞瘤)和功能状态已被证明是影响预后的因素。包括最佳放疗剂量和治疗时机在内的放疗的确切作用仍不清楚。这样的回顾性分析所提供的信息有助于设计前瞻性随机研究,以探讨放疗剂量以及手术和放疗干预的时间,同时始终需要仔细评估生活质量和治疗的并发症。